Anteo Technologies Pty Ltd is an Australian nanotechnology company, developing and commercialising products in the life sciences research, in-vitro diagnostics, energy and medical devices markets.
Anteo Technologies Pty Ltd is a fully-owned subsiduary of Anteo Diagnostics Ltd, an ASX listed company (ASX:ADO).
Utilising Anteo’s surface chemistry technology, we have developed the AnteoBind™ family of reagents that use multi-component coordination interactions to gently attach macromolecules to the surfaces of a variety of materials in various applications and devices.
Our chemistry can be used as a primer or binder to adhere synthetic polymers to change material surface properties. For biological molecules like proteins, multi-component binding minimizes functional damage to their biological activity. This is critical in in vitro diagnostics and medical devices.
Where existing covalent or passive binding methods had previously rendered antibodies non-functional, Anteo’s surface chemistry succeeded in producing functional assays.
"AnteoBind™ combines the ease-of-handling of passive adsorption with the binding-strength of covalent chemistry."
- One-Step surface activation
- Co-coupling two or more biomolecules in defined ratios Improved reproducibility
- Protein coupling in 1 hour
- Water-based chemistry with ready-to-use reagents